Vaccines are one of the most powerful immunomodulators and represent perspective direction in the modern strategy of treatment of cancer. Among the gynecological malignancies cervical cancer is the most perspective localization for the implementation of specific therapeutic vaccine, by reason of clear viral ethiopathogenesis and important medical and social effect of the disease. Nowadays, the therapeutic HPV vaccines under research, for precancer and cancer of uterine cervix aimed to eliminate the persistent viral infection. In the review, the results of several clinical trials concerning the effect of HPV vaccines, created on the basis of viral peptides, viral like particles, DNA and viral vectors have been discussed.

Download full-text PDF

Source

Publication Analysis

Top Keywords

precancer cancer
8
cancer uterine
8
uterine cervix
8
therapeutic hpv
8
hpv vaccines
8
viral
5
[vaccines precancer
4
cancer
4
cervix therapeutic
4
hpv vaccines]
4

Similar Publications

Introduction: Cervical cancer remains the second most common cancer among women worldwide, with 85% of cases occurring in low-and middle-income countries (LMIC). Women living with HIV (WLWH) are at a particularly high risk of developing for high-grade cervical intraepithelial neoplasia (CIN2/3) and cervical cancer, and the standard surgical treatment is far less effective in this population. Thus, research on medical therapies and combination treatment options remain a priority.

View Article and Find Full Text PDF

Background: Pre-cancer onset of cachexia raises uncertainties regarding the optimal timing for early intervention in lung cancer patients. We aimed to examine changes in physical function, nutritional status, and cachexia incidence in patients with lung cancer from the initial visit to treatment initiation and determine the effect of these changes on lung cancer treatment.

Methods: This single-center retrospective cohort study enrolled patients suspected of having advanced lung cancer who visited Kansai Medical University Hospital between January and February 2023 and were definitely diagnosed with the disease.

View Article and Find Full Text PDF

Dentistry still faces difficulties in diagnosing oral precancer and cancer, especially when it comes to early phase changes or disease detection, evaluation, and treatment. In essence, oral lumenography is the process of identifying oral lesions using a chemiluminescent light source and a toluidine blue labeling system. Since neoplastic epithelial cells have a changed nuclear-cytoplasmic ratio, acetic acid dehydration brings out this nuclear density and gives the tissue an "acetowhite" look.

View Article and Find Full Text PDF

Models for Studying Ductal Carcinoma In Situ Progression.

Adv Exp Med Biol

January 2025

Department of Pathology and Laboratory Medicine, MS 3045, The University of Kansas Medical Center, Kansas City, KS, USA.

An estimated 55,720 new cases of ductal carcinoma in situ (DCIS) will be diagnosed in 2023 in the USA alone because of the increased use of screening mammography. The treatment goal in DCIS is early detection and treatment with the hope of preventing progression into invasive disease. Previous studies show progression into invasive cancer as well as reduction in mortality from treatment is not as high as previously thought.

View Article and Find Full Text PDF

Statement Of The Problem: Oral squamous cell carcinoma (OSCC) is the most common type of oral cancer. During the invasion, tumour cells break through the basement membrane and penetrate the connective tissue to interact with the extracellular matrix. An attempt was made to evaluate the connective tissue changes in different grades of OSCCs, oral submucous fibrosis (OSMF) and Oral Epithelial Dysplasias.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!